Home » Market News » DirectorsTalk Highlights » Inhaling away the virus: Is the next generation of COVID vaccines on its way?
Open Orphan plc

Inhaling away the virus: Is the next generation of COVID vaccines on its way?

“This vaccine is one of the first of the next generation COVID-19 vaccines, it is a single dose, needle free, intranasal, live attenuated COVID-19 virus vaccine.” Cathal Friel, Executive Chairman, of Open Orphan, the company running the trials said in a statement.

To make it to the finish line, the vaccine will need to prove it’s safe and effective in three stepwise experimental ‘phases’ – a process that could take many months.

Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company comprises of two commercial specialist CRO services businesses (Venn Life Sciences and hVIVO) and is also developing a genomics data platform business (Genomic Health Data).